Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
复制标题
DOI:
10.1084/jem.20052283
复制
发表时间:
2006-03-20
影响因子:
15.3
通讯作者:
Tedder, TF
中科院分区:
文献类型:
--
作者:
Hamaguchi, Y;Xiu, Y;Komura, K;Nimmerjahn, F;Tedder, TF
CD20 monoclonal antibody (mAb) immunotherapy is effective for lymphoma and autoimmune disease. In a mouse model of immunotherapy using mouse anti–mouse CD20 mAbs, the innate monocyte network depletes B cells through immunoglobulin (Ig)G Fc receptor (FcγR)-dependent pathways with a hierarchy of IgG2a/c>IgG1/IgG2b>IgG3. To understand the molecular basis for these CD20 mAb subclass differences, B cell depletion was assessed in mice deficient or blocked for stimulatory FcγRI, FcγRIII, FcγRIV, or FcR common γ chain, or inhibitory FcγRIIB. IgG1 CD20 mAbs induced B cell depletion through preferential, if not exclusive, interactions with low-affinity FcγRIII. IgG2b CD20 mAbs interacted preferentially with intermediate affinity FcγRIV. The potency of IgG2a/c CD20 mAbs resulted from FcγRIV interactions, with potential contributions from high-affinity FcγRI. Regardless, FcγRIV could mediate IgG2a/b/c CD20 mAb–induced depletion in the absence of FcγRI and FcγRIII. In contrast, inhibitory FcγRIIB deficiency significantly increased CD20 mAb–induced B cell depletion by enhancing monocyte function. Although FcγR-dependent pathways regulated B cell depletion from lymphoid tissues, both FcγR-dependent and -independent pathways contributed to mature bone marrow and circulating B cell clearance by CD20 mAbs. Thus, isotype-specific mAb interactions with distinct FcγRs contribute significantly to the effectiveness of CD20 mAbs in vivo, which may have important clinical implications for CD20 and other mAb-based therapies.
登录
查看更多内容
影响因子:
4.4
作者:
Hamaguchi, Y;Uchida, J;Tedder, TF
通讯作者:
Tedder, TF
影响因子:
32.4
作者:
Ioan-Facsinay, A;de Kimpe, SJ;Verbeek, JS
通讯作者:
Verbeek, JS
影响因子:
158.5
作者:
KAMINSKI, MS;ZASADNY, KR;WAHL, RL
通讯作者:
WAHL, RL
影响因子:
5.4
作者:
Markine-Goriaynoff, D;Coutelier, JP
通讯作者:
Coutelier, JP
影响因子:
3.2
作者:
Mechetina, LV;Najakshin, AM;Taranin, AV
通讯作者:
Taranin, AV